However, when compared to insulin glargine, the GLP-1 receptor agonist dulaglutide demonstrated a more favorable effect on kidney function in patients with type 2 diabetes and moderate-to-severe kidney disease [38]. This evidence concerns the gene GLP1R and kidney disorder.